|
The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe |
Medicines for Europe |
07 Feb 2020 |
Health & Consumers, InfoSociety |
|
The off-patent medicines industry is a vital part of the solution for healthcare resilience |
Medicines for Europe |
30 Jun 2022 |
Health & Consumers |
|
Time for the EU to take steps: a medicines security act is needed for health security |
Medicines for Europe |
02 Oct 2023 |
Health & Consumers |
|
Time to modernise the eu pharmaceutical regulatory framework to deliver on access |
Medicines for Europe |
30 Jan 2020 |
Health & Consumers, InfoSociety |
|
US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver |
Medicines for Europe |
22 Oct 2018 |
Health & Consumers |
|
Value added medicines: Continuous innovation crucial to improve healthcare across Europe |
Medicines for Europe |
21 Nov 2018 |
Health & Consumers |
|
Value Added Medicines: Time to adjust the HTA Decision Frameworks for more patient-centric innovation |
Medicines for Europe |
05 Sep 2017 |
Health & Consumers |
|
Vigilance saves lives! More focus needed on sustainability and patient engagement |
Medicines for Europe |
24 Jan 2018 |
Health & Consumers |
|
Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks |
Medicines for Europe |
19 Jan 2021 |
Health & Consumers |
|
‘Health revolution’: when smart innovation benefits patients |
Medicines for Europe |
21 Nov 2019 |
Health & Consumers |
|
‘Together for Health’: Medicines for Europe launches election manifesto to deliver on equitable patient access |
Medicines for Europe |
03 Apr 2019 |
Health & Consumers |
